NAM
ORGO icon

Nissay Asset Management’s Organogenesis Holdings ORGO Stock Holding History

Nissay Asset Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-52,907
Closed -$403K – 766
2022
Q1 		$403K Hold
52,907
– – ﹤0.01% 710
2021
Q4 		$489K Hold
52,907
– – ﹤0.01% 704
2021
Q3 		$753K Hold
52,907
– – 0.01% 666
2021
Q2 		$879K Buy
+52,907
New +$986K 0.01% 655

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nissay Asset Management's ORGO Position: Q2 2022 in Review

Nissay Asset Management sold out of Organogenesis Holdings (ORGO) in Q2 2022, closing a stake of 52,907 shares — an estimated $403K sold.

Nissay Asset Management first reported a position in ORGO in Q2 2021 and held it in 4 quarters. The position peaked at $879K in Q2 2021. 146 funds tracked by Wall St. Rank hold ORGO as of Q2 2022.

  • Nissay Asset Management reported no remaining Organogenesis Holdings position as of Q2 2022 after selling out during the quarter.
  • Nissay Asset Management sold 52,907 Organogenesis Holdings shares in Q2 2022, an estimated $403K.
  • Nissay Asset Management first reported a position in Organogenesis Holdings in Q2 2021 and held it in 4 quarters.
  • Nissay Asset Management's Organogenesis Holdings position peaked at $879K in Q2 2021.
  • 146 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2022.

Based on Nissay Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.